AXA Framlington UK Growth R

An actively managed core UK portfolio with a bias to mid cap.

  • 216.10p
    Price (Inc)

    These are the shares in the fund that pay out an income to clients. The income is made up of the total dividends – the money a company can pay out to its investors – from the companies in the fund.

  • 326.60p
    Price (Acc)

    These are the shares in the fund that don’t pay out an income to clients. Any dividends – the money a company can pay out to its investors – are reinvested into companies in the fund. Despite no income, the shares should be worth more over time. Good incentive, eh?

  • 5.25% 0.00%

    Initial charge

    Some funds charge you when you first invest, which is aptly known as the initial charge. They’re usually between 3-5% but at Bestinvest, we usually don’t charge you a penny!

  • 1.50%
    Annual management charge

    This is how much the fund management company charges to run the fund. It’s like paying a babysitter, dog sitter or house sitter (that makes well-informed, heavily researched changes to improve your baby/dog/house when needed).

  • 1.59%
    Ongoing charges

    This stands for Ongoing Charges Figure. It’s the cost of running a fund and includes admin fees, manager fees, administration costs, etc.

  • 1.20%
    Yield

    How much the fund is currently paying out in income to investors. It’s NOT to be confused with the overall growth of a fund – a very different thing indeed. It’s also NOT a guarantee of future pay-outs, just a snapshot. This is more what it’s not than what it is…

Prices as at 18 September 2020, fund data last updated 11 August 2004

The fund's objective is to achieve capital growth through investment principally in UK large and medium capitalisation companies which, in the Manager's opinion, show above average profitability, management quality and growth.

Fund summary

Sector UK All Companies
Structure UNIT TRUST
Launched December, 1992
Size £149m
Yield 1.20%
Charging basis Income
Dividends paid 15 Jul

Charges

Standard initial charge 5.25%
Initial charge via Bestinvest 0.00%
Additional bid/offer spread 0.00%
Annual management charge 1.50%
Ongoing charges figure 1.59%

Allocation

Proportion (%)

  • {{chartDataItem.text}}
    {{chartDataItem.value}}

Allocation

Proportion (%)

  • {{chartDataItem.text}}
    {{chartDataItem.value}}

Allocation

Proportion (%)

  • {{chartDataItem.text}}
    {{chartDataItem.value}}

Investment process

Manager research

Average monthly relative returns

  • 15/16 -0.22%
  • 16/17 -0.36%
  • 17/18 0.01%
  • 18/19 0.45%
  • 19/20 1.08%

Bestinvest MRI

  • 3 years 0.51%
  • 5 years 0.19%
  • Career 0.10%
  • 3 years 99.90%
  • 5 years 93.70%
  • Career 98.00%

Performance figures are based on the average of monthly percentage returns relative to the benchmark index.

Jamie Hooper

Hooper joined AXA Framlington in November 2006 and is a fund manager covering UK Growth. Prior to a career in asset management, he worked for Barclays plc for 8 years from 1987 as a senior corporate advances analyst. In 1995 he became a UK Equity Analyst at London & Manchester, a group which subsequently evolved through numerous mergers into the F&C Asset Management. Hooper has passed his Associate examinations for the Chartered Institute of Bankers and the UK Society of Investment Professionals (formerly AIIMR).

Track record

Jamie Hooper has 16.2 years experience of managing mutual funds in this sector. Over this period the average monthly return relative to the benchmark index has been +0.1%. During the worst period of relative performance (from September 2002 - October 2008) there was a decline of 11% relative to the index. The worst absolute loss has been 39%. Statistically, we estimate the probability that this fund manager is adding value, rather than being lucky, is 98%.

Periods of worst performance

Absolute -39.00% (May 2007 - February 2009)
Relative -11.00% (September 2002 - October 2008)

About the MRI

Our unique indicator: the Bestinvest Manager Record Index (MRI) measures the likelihood that the fund manager is adding value through their decisions. It is based on their performance record over the course of their career, adjusted for the amount of risk taken. MRI is an important contributor to our fund rating system but it is also vital to take account of qualitative factors. It is also very important to select funds to form a cohesive portfolio with an appropriate overall risk level.

Allocation

Proportion (%)

  • {{chartDataItem.text}}
    {{chartDataItem.value}}

Allocation

Proportion (%)

  • {{chartDataItem.text}}
    {{chartDataItem.value}}

Allocation

Proportion (%)

  • {{chartDataItem.text}}
    {{chartDataItem.value}}

Top 10 holdings

Data accurate as at 31 July 2020

6.08% Astrazeneca Plc
5.13% Reckitt Benckiser Group Plc
4.31% Bp
4.22% Glaxosmithkline
3.93% Diageo
3.01% London Stock Exchange Group
2.9% Experian Plc
2.84% Rentokil Initial Plc
2.79% Prudential Plc
2.69% Legal & General Group
Source: Trustnet

Sector breakdown

Financials 22.00%
Health Care 19.00%
Industrials 16.00%
Consumer Goods 12.00%
Technology 8.00%
Money Market 6.00%
Consumer Services 6.00%
Oil & Gas 5.00%
Utilities 2.00%
Basic Materials 2.00%

Key Investor Information - Income

Download

Key Investor Information - Accumulation

Download